Argus downgraded Silk Road Medical to Hold from Buy.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SILK:
- Silk Road Medical initiated with an Outperform at Oppenheimer
- Silk Road Medical to Present at the CL King 21st Annual Best Ideas Conference
- Silk Road Medical price target lowered to $35 from $48 at Citi
- Silk Road Medical to Present at the UBS MedTech, Tools and Genomics Summit
- Silk Road Medical price target lowered to $45 from $50 at Stifel